DELCATH SYSTEMS, INC. DCTH
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2000-10-19
DELCATH SYSTEMS, INC. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $85.2M | $37.2M | $2.1M | $2.7M | $3.6M |
| Gross profit | $73.4M | $31.0M | $1.4M | $2.0M | $2.9M |
| R&D expense | $29.2M | $13.9M | $17.5M | $18.6M | $13.8M |
| SG&A expense | $43.5M | $29.6M | $22.1M | $17.3M | $13.6M |
| Operating income | $660,000 | -$12.4M | -$38.2M | -$33.9M | -$24.5M |
| Income tax | $810,000 | $0 | $0 | $0 | $0 |
| Net income | $2.7M | -$26.4M | -$47.7M | -$36.5M | -$25.6M |
| EPS (diluted) | $0.07 | $-0.93 | $-2.94 | $-4.12 | $-3.59 |
| Operating cash flow | $22.5M | -$18.7M | -$31.3M | -$24.9M | -$22.6M |
| Free cash flow | $21.0M | -$19.2M | -$31.3M | -$25.2M | -$22.7M |
| Cash & equivalents | $43.5M | $32.4M | $12.6M | $7.7M | $22.8M |
| Inventory | $10.3M | $6.9M | $3.3M | $2.0M | $1.4M |
| Total assets | $123.6M | $76.6M | $38.6M | $17.9M | $33.1M |
| Total liabilities | $12.4M | $7.8M | $22.8M | $23.7M | $21.2M |
| Shareholders' equity | $111.2M | $68.7M | $15.8M | -$5.9M | $12.0M |
Source: SEC EDGAR filings · CIK 0000872912 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.